【呼吸器内科】
・Assessment of serum periostin level as a predictor of requirement for intensive treatment for type-2
inflammation in asthmatics in future: A follow-up study of the KiHAC cohort.
Sunadome H, et al., Allergol Int 2021, 70:252-254.
・IL4Rα and ADAM33 as genetic markers in asthma exacerbations and type-2 inflammatory endotype.
Sunadome H, et al., Clin Exp Allergy 2017, 47:998-1006.
・Utility of serum periostin in combination with exhaled nitric oxide in the management of asthma.
Nagasaki T, et al., Allergol Int 2017, 66:404-410
・Staphylococcus aureus enterotoxin sensitization involvement and its association with CysLTR1 variant in
different asthma phenotypes. Matsumoto H, et al., Ann Allergy Asthma Immunol 2017, 118:197-203.
・Serum periostin: A Novel Biomarker for Asthma Management.
Matsumoto H., Allergol Int 2014, 63:153-160.
・Factors Contributing to an Accelerated Decline in Pulmonary Function in Asthma.
Kanemitsu Y. et al., Allergol Int 2014, 63:181-188.
・Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive
asthma. Nagasaki T, et al., Am J Respir Crit Care Med 2014, 190; 1149-52.
・Integrating longitudinal information on pulmonary function and inflammation using asthma phenotypes.
Nagasaki T, et al., J Allergy Clin Immunol 2014,133:1474-1477.
・GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids.
Izuhara Y, et al., Allergy 2014, 69:668-73.
・Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids.
Kanemitsu Y, et al., J Allergy Clin Immunol 2013, 132:305-12.
呼吸器内科 | 学会発表 | 国内 | 6 |
海外 | 5 | ||
投稿論文 | 国内 | 2 | |
海外 | 10 | ||
小 児 科 | 学会発表 | 国内 | 5 |
海外 | 2 | ||
投稿論文 | 国内 | 2 | |
耳鼻咽喉科 | 学会発表 | 国内 | 2 |
投稿論文 | 国内 | 5 |